Published in Gene Therapy Weekly, November 10th, 2005
Test results using the AmpliChip CYP450, which is powered by Affymetrix microarray technology, will allow physicians to consider genetic information from patients in selecting medications and doses for a several common conditions such as pain medication, cardiac disease, cancer and depression. The AmpliChip CYP450 assay analyzes a patient's Cytochrome P450 2D6 and 2C19 genotypes from genomic DNA extracted...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.